Search

Search Constraints

You searched for: Author/Creator Yamaguchi, Motoko

Search Results

1. A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma. Issue 7 (4th June 2021)

2. Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy. Issue 6 (28th April 2018)

5. Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma. Issue 4 (2nd March 2022)

7. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial. Issue 11 (November 2018)

8. Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy. Issue 11 (4th October 2014)

9. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Issue 4 (April 2020)